CN106617263A - Ointment-form snuff and preparation method thereof - Google Patents
Ointment-form snuff and preparation method thereof Download PDFInfo
- Publication number
- CN106617263A CN106617263A CN201611257416.7A CN201611257416A CN106617263A CN 106617263 A CN106617263 A CN 106617263A CN 201611257416 A CN201611257416 A CN 201611257416A CN 106617263 A CN106617263 A CN 106617263A
- Authority
- CN
- China
- Prior art keywords
- snuff
- ointment
- ointment type
- furfural
- type snuff
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B13/00—Tobacco for pipes, for cigars, e.g. cigar inserts, or for cigarettes; Chewing tobacco; Snuff
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
Abstract
The invention belongs to the field of tobacco products, and discloses ointment-form snuff and a preparation method thereof. The ointment-form snuff is prepared from the following materials in percentage by mass: 43-44% of paraffin wax, 17-21% of petroleum jelly, 2.4-3% of penetration enhancer, 6.2-7.8% of nicotine, 1.9-2.5% of cotinine, 2.3-5.1% of neophytadiene, 0.34-0.49% of furfural, 0.5-0.9% of ionol, 0.43-0.56% of megastigmatrienone and the like; and the pH value of the ointment-form snuff is 4.7-5.9. The ointment-form snuff provided by the invention, as a substitute of conventional cigarettes, is similar with the conventional cigarettes in such qualities as aroma, strength, taste and the like. The ointment-form snuff is relatively small in size, convenient to carry and broad in application scope, and the ointment-form snuff, which does not need to be burned, can avoid fire disaster, avoid influence of smoke to people around and avoid secondhand smoking.
Description
Technical field
The invention belongs to tobacco product field, more particularly, to a kind of ointment type snuff and preparation method thereof.
Background technology
At present the smokeless tobacco articles on overseas market mostly are tobacco powder product, more with packed buccal cigarette, bulk form
The form such as buccal cigarette, snuff exist.Tobacco chewing gum as smokeless tobacco articles a kind of important supplement form, by chew
Process, improves the uniformity of nicotine release, improves the mouthfeel harmony of smokeless tobacco articles, meets the physiology need of tobacco consumer
While asking, increase the process enjoying sense that tobacco consumer eats, while also cleanable tooth, fresh breath, pre- anti-caries.
However, tobacco extract is typically directly added into the form of paste or powder in existing smokeless tobacco articles.But
In smokeless tobacco articles, due to change of the consumer to the absorption mode of the materials such as nicotine in product, if by tobacco extract
In being directly added into product, can cause the materials such as nicotine discharge in consumer oral cavity soon, the duration is short, mouthfeel excitement strong,
As entrance thick taste, strength, excitant are excessive, a few minutes taste is thin out, and hamony is deteriorated, and process enjoying sense is poor, serious shadow
Ring consumer to require smokeless tobacco articles comfortableness.
Existing sustained release tobacco microcapsules or micro- smoked sheet are generally simply using coating material to tobacco extract or tobacco leaf
Coated.However, existing product also just loses the function of sustained release after coating dissolving.Containing above-mentioned microcapsules or micro-
The smokeless tobacco articles of smoked sheet, in the starting stage of edible process, in product the content of microcapsules or micro- smoked sheet still than larger,
It is also larger with the contact area of oral cavity or saliva, therefore, the material such as nicotine of starting stage release is more, and mouthfeel still compares thorn
Swash, after eating a period of time, diminish with the volume of microcapsules or micro- smoked sheet, quantity is also reduced, and then the rate of release of nicotine,
Burst size also reduces therewith, and consumer remains to significantly experience the decline of mouthfeel and quality in use, do not reach with
Smoking identical is experienced.
The content of the invention
The technical problem to be solved in the present invention is the defect for overcoming prior art, there is provided a kind of ointment at nasal cavity
Type snuff.
Another object of the present invention is to provide a kind of preparation method of the ointment type snuff.
The present invention is achieved through the following technical solutions:
A kind of ointment type snuff, is made up of the material of following mass percent:
Paraffin 43%~44%, vaseline 17%~21%, penetrating agent 2.4% ~ 3%, nicotine 6.2% ~ 7.8%, cotinine 1.9% ~ 2.5%,
Neophytadiene 2.3% ~ 5.1%, furfural 0.34% ~ 0.49%, ionol 0.5% ~ 0.9%, Megastigmatrienone 0.43% ~ 0.56%, eggplant
Ketone 2.3% ~ 2.7%, geranyl acetone 0.25% ~ 0.62%, catechol 3.3% ~ 4.24%, D- phellandrenes 1.2% ~ 1.4%, myrcene
1.2% ~ 2.3%, pyridine 0.37% ~ 0.41%, preservative 0.01% ~ 0.015%, sodium glycocholate 0.03 ~ 0.11%, 5 hydroxymethyl furfural
0.12 ~ 0.15%, irisone 0.3 ~ 0.6%, violaxanthin 0.17 ~ 0.30%, appropriate pH value regulator, balance of stearic acid;It is described
The pH of ointment type snuff is 4.7 ~ 5.9.
The invention provides a kind of substitute of conventional cigarette, takes granule and be put into nasal cavity, using having crowd on bronchia mucosal
Many trickle fine hair, greatly increases the effective surface area for smearing cigarette absorption, it is upper it is subcutaneous have an abundant capillary, pharynx nasalis enriches
Lymphatic vessel the ingredient draws for smearing cigarette are also played an important role, ingredient draws are rapid.Smear after cigarette absorbs and be directly entered body
Circulate, not trans-portal vein, without liver first-pass effect, bronchia mucosal is atomic to drug metabolism weak, and bioavilability is high.
Just because of the olfactive characteristics and absorption characteristic at nasal cavity position are very special and sensitivity, the present invention is put into nasal cavity
Smear cigarette strictly to control composition and ratio, just with qualities such as similar fragrance, strength, the tastes to conventional cigarette.
Because nasal cavity, nasal sinus and cranium brain relation are extremely close, not only there are potential fine channel, and 12 between nose cranium
To having 3 to be distributed in bronchia mucosal to (trifacial ramus ophthalmicus and ramus maxillaris, olfactory nerve and Branches of facial nerve) in cranial nerve.Cause
This, can stimulate intranasal nerve after the composition intranasal such as nicotine so as to produce reflectivity regulation, adjust brain and viscera function, so as to
Therapeutic action is played to brain and whole body.
Preferably, ointment type snuff can add appropriate pH value regulator, such as citric acid, lactic acid, tartaric acid, sodium carbonate,
One or more in sodium acid carbonate, disodium hydrogen phosphate etc..
Preferably, the neophytadiene, furfural, solanone, the mass ratio of myrcene are 3:0.4:2.4:1.5;The 5- hydroxyls
Methyl furfural, irisone, the mass ratio 13 of violaxanthin:44:23.With with cigarette identical fragrance.
Preferably, the nicotine, cotinine, the mass ratio of Megastigmatrienone are 7:2.3:0.45.
Preferably, a kind of ointment type snuff is made up of the material of following mass percent:
Paraffin 43%, vaseline 18%, penetrating agent 3%, nicotine 7%, cotinine 2.3%, neophytadiene 4%, furfural 0.5%, ionol
0.9%th, Megastigmatrienone 0.45%, solanone 2.4%, geranyl acetone 0.6%, catechol 3.4%, D- phellandrenes 1.3%, myrcene
2.0%th, pyridine 0.4%, preservative 0.01%, sodium glycocholate 0.09%, 5 hydroxymethyl furfural 0.13%, irisone 0.44%, purple Huang
Matter 0.23%, appropriate pH value regulator, balance of stearic acid;The pH of the ointment type snuff is 4.9.
Preferably, a kind of ointment type snuff is made up of the material of following mass percent:
Paraffin 44%, vaseline 18%, penetrating agent 2.6%, nicotine 7%, cotinine 2.3%, neophytadiene 3%, furfural 0.4%, violet
Alcohol 0.8%, Megastigmatrienone 0.45%, solanone 2.4%, geranyl acetone 0.6%, catechol 3.8%, D- phellandrenes 1.3%, myrcene
1.5%th, pyridine 0.39%, preservative 0.01%, sodium glycocholate 0.11%, 5 hydroxymethyl furfural 0.13%, irisone 0.44%, purple Huang
Matter 0.23%, appropriate pH value regulator, balance of stearic acid;The pH of the ointment type snuff is 5.7.
Preferably, penetrating agent is azone, and preservative is nipagin esters and its sodium salt.
A kind of preparation method of the ointment type snuff, comprises the following steps:
S1. weighing paraffin, vaseline, stearic acid and preservative and being put into melt pot adds heat fusing to be in a liquid state, after stirring,
It is filtrated to get mixed-matrix;
S2. mixed-matrix is put into blending tank, adds remaining component, seal blending tank, stirred at being heated to 90 DEG C ~ 100 DEG C
After uniform, both obtain after cooling.
Compared with prior art, the invention has the advantages that:
The present invention for ointment type snuff at nasal cavity as conventional cigarette substitute, with the similar perfume (or spice) to conventional cigarette
The qualities such as gas, strength, taste.
Have the advantages that ingredient draws are rapid, bioavilability is high for the ointment type snuff at nasal cavity, and nicotine
Deng intranasal nerve can be stimulated after composition intranasal so as to produce reflectivity regulation, adjust brain and viscera function, so as to brain and
Whole body plays therapeutic action.
The ointment type snuff small volume of the present invention is easy to carry and is avoided that fire, non smoke will not shadows without the need for burning
Ring the people to surrounding, it is to avoid second-hand-cigarette, it is applied widely.
Specific embodiment
The present invention is further illustrated with reference to specific embodiment.Unless stated otherwise, adopt in the embodiment of the present invention
Raw material, apparatus and method are routinely commercial raw material, the conventional use of apparatus and method in this area.
Embodiment 1
A kind of ointment type snuff, is made up of the material of following quality:
Paraffin 43g, vaseline 18g, azone 3g, nicotine 7g, cotinine 2.3g, neophytadiene 4g, furfural 0.5g, ionol
0.9g, Megastigmatrienone 0.45g, solanone 2.4g, geranyl acetone 0.6g, catechol 3.4g, D- phellandrene 1.3g, myrcene
2.0g, pyridine 0.4g, nipagin esters 0.01g, sodium glycocholate 0.09g, 5 hydroxymethyl furfural 0.13g, irisone 0.44g, purple
Yellow matter 0.23g, stearic acid 9.78g, sodium acid carbonate 0.12g, the pH of obtained ointment type snuff is 4.9.
The preparation method of ointment type snuff, comprises the following steps:
S1. paraffin, vaseline, stearic acid and the preservative for weighing above-mentioned metering is put into melt pot plus heat fusing is in a liquid state, and stirs
After mixing uniformly, mixed-matrix is filtrated to get;
S2. mixed-matrix is put into blending tank, adds remaining component, seal blending tank, stirred at being heated to 90 DEG C ~ 100 DEG C
After uniform, both obtain after cooling.
Embodiment 2 ~ 5
Embodiment 2 ~ 5 is substantially the same manner as Example 1, and difference is that the content proportioning of each component is as shown in table 1:
Table 1(Unit:g)
Embodiment 2 | Embodiment 3 | Embodiment 4 | Embodiment 5 | |
Paraffin | 44 | 43 | 43 | 44 |
Vaseline | 18 | 21 | 17 | 20 |
Azone | 2.6 | 2.4 | 3 | 2 |
Nicotine | 7 | 6.2 | 7 | 7.8 |
Cotinine | 2.3 | 1.9 | 2.2 | 2.5 |
Neophytadiene | 3 | 5.1 | 5 | 2.3 |
Furfural | 0.4 | 0.34 | 0.49 | 0.4 |
Ionol | 0.8 | 0.5 | 0.7 | 0.9 |
Megastigmatrienone | 0.45 | 0.56 | 0.4 | 0.5 |
Solanone | 2.4 | 2.3 | 2.7 | 2.5 |
Geranyl acetone | 0.6 | 0.4 | 0.25 | 0.35 |
Catechol | 3.8 | 4.2 | 3.3 | 4 |
D- phellandrenes | 1.3 | 1.4 | 1.2 | 1.3 |
Myrcene | 1.5 | 1.2 | 1.9 | 2.3 |
Pyridine | 0.39 | 0.41 | 0.35 | 0.4 |
Nipagin esters | 0.01 | 0.012 | 0.015 | 0.01 |
Sodium glycocholate | 0.11 | 0.03 | 0.08 | 0.1 |
5 hydroxymethyl furfural | 0.13 | 0.15 | 0.12 | 0.14 |
Irisone | 0.44 | 0.6 | 0.3 | 0.53 |
Violaxanthin | 0.23 | 0.25 | 0.17 | 0.3 |
Stearic acid | 9.94 | 6.948 | 10.325 | 7.38 |
PH value regulator | Sodium carbonate, 0.6 | Sodium acid carbonate, 1.1 | Disodium hydrogen phosphate, 0.5 | Lactic acid, 0.29 |
pH | 4.7 | 5.2 | 5.6 | 5.9 |
Comparative example 1
Paraffin 43g, vaseline 18g, azone 3g, nipagin esters 0.01g, tobacco smoke oil extractum 12g, stearic acid 23.99g.
The preparation method of tobacco smoke oil extractum:To pulverize after Tobacco drying, tobacco powder is obtained, take tobacco powder and be placed in burning
In cup, distilled water, stirring is added to run through, tobacco powder is 35-45 with the weight proportion of distilled water:600-1000, soaks 1-2
After hour, ultrasonic wave extraction separation is carried out, after extracting 25-35 minutes, filtered, it is (relative that filtrate is condensed into tobacco tobacco tar liquid extract
Density, 1mL is equivalent to tobacco 1g), re-dry is obtained tobacco tobacco tar thick medicinal extract (0.6mL is equivalent to tobacco 1g).
The preparation method of ointment type snuff, comprises the following steps:
S1. paraffin, vaseline, stearic acid and the preservative for weighing above-mentioned metering is put into melt pot plus heat fusing is in a liquid state, and stirs
After mixing uniformly, mixed-matrix is filtrated to get;
S2. mixed-matrix is put into blending tank, adds tobacco smoke oil extractum, seal blending tank, be heated at 90 DEG C ~ 100 DEG C
After stirring, both obtain after cooling.
Comparative example 2
Paraffin 44g, vaseline 18g, azone 3g, nipagin esters 0.01g, tobacco extract 32g, stearic acid 2.99g.
The preparation method of tobacco extract:
S11. the flue-cured tobacco that absolute dry mass is 100g is taken, adds 1400g water to carry out in 60 DEG C after immersion 25min, be cooled to 20 DEG C of left sides
The right side, the ultrasonic extraction 60min under the conditions of 25 ± 2 DEG C, the power of ultrasonic wave is 300W, and then vacuum draw is filtered, and obtains filter residue a
With filtrate a;
S12. after the ethanol of 7 times of absolute dry mass of filter residue a is added in the filter residue a of S11, the ultrasonic extraction under the conditions of 25 ± 2 DEG C
30min, the power of ultrasonic wave is 300W, and then vacuum draw is filtered, and obtains filter residue b and filtrate b;
S13. filtrate a and filtrate b is mixed, it is 15% that solid content is concentrated in vacuo under the conditions of 25 DEG C, obtains the tobacco and carries
Take thing.
The preparation method of ointment type snuff, comprises the following steps:
S1. paraffin, vaseline, stearic acid and the preservative for weighing above-mentioned metering is put into melt pot plus heat fusing is in a liquid state, and stirs
After mixing uniformly, mixed-matrix is filtrated to get;
S2. mixed-matrix is put into blending tank, adds tobacco extract, seal blending tank, stirred at being heated to 90 DEG C ~ 100 DEG C
After mixing uniformly, both obtain after cooling.
Comparative example 3 ~ 6
Comparative example 3 ~ 6 is substantially the same manner as Example 1, and difference is that the content proportioning of each component is as shown in table 2:
Table 2(Unit:g)
Comparative example 3 | Comparative example 4 | Comparative example 5 | Comparative example 6 | |
Paraffin | 44 | 43 | 43 | 44 |
Vaseline | 18 | 21 | 17 | 20 |
Azone | 2.6 | 2.4 | 3 | 2 |
Nicotine | 7 | 6.2 | 7 | 7.8 |
Cotinine | 2.3 | 1.9 | - | 2.5 |
Neophytadiene | 2 | 5.1 | 5 | 2.3 |
Furfural | 0.5 | 0.34 | 0.49 | 0.4 |
Ionol | 0.8 | 0.5 | 0.7 | 0.9 |
Megastigmatrienone | 0.45 | 0.56 | 0.4 | 0.5 |
Solanone | 2.8 | 2.3 | 2.7 | 2.5 |
Geranyl acetone | 0.6 | 0.4 | 0.25 | 0.35 |
Catechol | 3.8 | 4.2 | 3.3 | 4 |
D- phellandrenes | 1.3 | 1.4 | 1.2 | 1.3 |
Myrcene | 1.5 | 1.2 | 1.9 | 2.3 |
Pyridine | 0.39 | 0.41 | 0.35 | 0.4 |
Nipagin esters | 0.01 | 0.012 | 0.015 | 0.01 |
Sodium glycocholate | 0.11 | 0.03 | 0.08 | - |
5 hydroxymethyl furfural | 0.11 | 0.15 | 0.12 | 0.14 |
Irisone | 0.44 | 0.6 | 0.3 | 0.53 |
Violaxanthin | 0.15 | - | 0.17 | 0.3 |
PH value regulator | Sodium carbonate 0.53 | Sodium acid carbonate 2.7 | Disodium hydrogen phosphate 1.2 | Tartaric acid 0.97 |
Stearic acid | 10.61 | 5.598 | 11.825 | 6.8 |
pH | 4.7 | 5.2 | 5.6 | 5.9 |
The evaluation of effect
10 criticism persons for having smoking habit usually are chosen, everyone takes equivalent sample and is put into nasal cavity, according to ointment type snuff
The indexs such as fragrance, strength, outward appearance are given a mark, and try to achieve mean value record in the following table.
Evaluation criterion:
Fragrance:Fragrance is dense(10~8 points), fragrance it is thin(6~4 points), fragrance it is light(2~1 points)
Strength:Strength is moderate(10~8 points), strength it is big(6~4 points), strength it is little(2~1 points)
Excitant:It is little(10~8 points), in(6~4 points), it is big(2~1 points)
Miscellaneous taste:Nothing(10~8 points), it is heavier(6~4 points), it is serious(2~1 points)
Outward appearance:Quality and color are uniform(10~8 points), quality and colour-difference(6~4 points), quality and color it is very poor(2~1 points)
Evaluation result is as follows:
Fragrance | Strength | Excitant | Miscellaneous taste | Outward appearance | It is total | |
Embodiment 1 | 10 | 10 | 10 | 10 | 10 | 50 |
Embodiment 2 | 10 | 10 | 10 | 10 | 10 | 50 |
Embodiment 3 | 8 | 9 | 9 | 9 | 8 | 43 |
Embodiment 4 | 9 | 9 | 8 | 9 | 10 | 45 |
Embodiment 5 | 8 | 9 | 9 | 8 | 10 | 44 |
Comparative example 1 | 1 | 1 | 2 | 1 | 2 | 7 |
Comparative example 2 | 3 | 1 | 2 | 3 | 5 | 14 |
Comparative example 3 | 2 | 3 | 1 | 6 | 8 | 20 |
Comparative example 4 | 4 | 3 | 5 | 4 | 8 | 24 |
Comparative example 5 | 3 | 4 | 8 | 4 | 8 | 27 |
Comparative example 6 | 6 | 3 | 4 | 6 | 6 | 25 |
It can be seen from above-mentioned evaluation result, ointment type snuff prepared by embodiment 1~5 selection of component and is matched somebody with somebody on the whole
Than reasonable, product has the advantage of excellent fragrance, strength, excitant and miscellaneous taste very little, and product provides one kind to consumer
The experience similar to conventional cigarette.Neophytadiene, furfural, solanone, myrcene are added with specific ratio in embodiment 1 ~ 2, are carried
Supplied a kind of most widely suited fragrance, at the same nicotine, cotinine, Megastigmatrienone ratio combination ensure that product strength and
Absorbing state, the quality of product is more excellent.Knowable to comparative example 1 ~ 2, the tobacco tobacco tar thick medicinal extract or cigarette of extraction from tobacco
Careless extract is used as tobacco ingredient, and its fragrance for obtaining and strength etc. are all very poor, is especially the absence of the generation of cigarette extracting combustion
Fragrance;Its composition complex stimulus is very strong, the shortcomings of miscellaneous taste is dense.Comparative example 3 ~ 6 understands usage ratio, pH, the sweet courage of each material
The factors such as sour sodium have very big negative effect to the fragrance of ointment type snuff, strength, excitant.
Claims (7)
1. a kind of ointment type snuff, it is characterised in that be made up of the material of following mass percent:
Paraffin 43%~44%, vaseline 17%~21%, penetrating agent 2.4% ~ 3%, nicotine 6.2% ~ 7.8%, cotinine 1.9% ~ 2.5%,
Neophytadiene 2.3% ~ 5.1%, furfural 0.34% ~ 0.49%, ionol 0.5% ~ 0.9%, Megastigmatrienone 0.43% ~ 0.56%, eggplant
Ketone 2.3% ~ 2.7%, geranyl acetone 0.25% ~ 0.62%, catechol 3.3% ~ 4.24%, D- phellandrenes 1.2% ~ 1.4%, myrcene
1.2% ~ 2.3%, pyridine 0.37% ~ 0.41%, preservative 0.01% ~ 0.015%, sodium glycocholate 0.03 ~ 0.11%, 5 hydroxymethyl furfural
0.12 ~ 0.15%, irisone 0.3 ~ 0.6%, violaxanthin 0.17 ~ 0.30%, appropriate pH value regulator, balance of stearic acid;It is described
The pH of ointment type snuff is 4.7 ~ 5.9.
2. ointment type snuff according to claim 1, it is characterised in that the neophytadiene, furfural, solanone, myrcene
Mass ratio is 3:0.4:2.4:1.5;The 5 hydroxymethyl furfural, irisone, the mass ratio 13 of violaxanthin:44:23.
3. ointment type snuff according to claim 2, it is characterised in that the nicotine, cotinine, the quality of Megastigmatrienone
Than for 7:2.3:0.45.
4. ointment type snuff according to claim 1, it is characterised in that be made up of the material of following mass percent:
Paraffin 43%, vaseline 18%, penetrating agent 3%, nicotine 7%, cotinine 2.3%, neophytadiene 4%, furfural 0.5%, ionol
0.9%th, Megastigmatrienone 0.45%, solanone 2.4%, geranyl acetone 0.6%, catechol 3.4%, D- phellandrenes 1.3%, myrcene
2.0%th, pyridine 0.4%, preservative 0.01%, sodium glycocholate 0.09%, 5 hydroxymethyl furfural 0.13%, irisone 0.44%, purple Huang
Matter 0.23%, appropriate pH value regulator, balance of stearic acid;The pH of the ointment type snuff is 4.9.
5. ointment type snuff according to claim 1, it is characterised in that be made up of the material of following mass percent:
Paraffin 44%, vaseline 18%, penetrating agent 2.6%, nicotine 7%, cotinine 2.3%, neophytadiene 3%, furfural 0.4%, violet
Alcohol 0.8%, Megastigmatrienone 0.45%, solanone 2.4%, geranyl acetone 0.6%, catechol 3.8%, D- phellandrenes 1.3%, myrcene
1.5%th, pyridine 0.39%, preservative 0.01%, sodium glycocholate 0.11%, 5 hydroxymethyl furfural 0.13%, irisone 0.44%, purple Huang
Matter 0.23%, appropriate pH value regulator, balance of stearic acid;The pH of the ointment type snuff is 5.7.
6. the ointment type snuff according to Claims 1 to 5 any one, it is characterised in that penetrating agent is azone, and preservative is
Nipagin esters and its sodium salt.
7. a kind of preparation method of the snuff of ointment type according to claim 6, it is characterised in that comprise the following steps:
S1. weighing paraffin, vaseline, stearic acid and preservative and being put into melt pot adds heat fusing to be in a liquid state, after stirring,
It is filtrated to get mixed-matrix;
S2. mixed-matrix is put into blending tank, adds remaining component, seal blending tank, stirred at being heated to 90 DEG C ~ 100 DEG C
After uniform, both obtain after cooling.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611257416.7A CN106617263A (en) | 2016-12-30 | 2016-12-30 | Ointment-form snuff and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611257416.7A CN106617263A (en) | 2016-12-30 | 2016-12-30 | Ointment-form snuff and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106617263A true CN106617263A (en) | 2017-05-10 |
Family
ID=58837824
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611257416.7A Pending CN106617263A (en) | 2016-12-30 | 2016-12-30 | Ointment-form snuff and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106617263A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108968165A (en) * | 2018-10-10 | 2018-12-11 | 湖北中烟工业有限责任公司 | A method of improving electronic cigarette and aspirates strength |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN86106959A (en) * | 1985-09-19 | 1987-05-20 | 贝特莱夫国际公司 | Herbal chewing tobacco and snuff composition |
CN1081908A (en) * | 1993-08-31 | 1994-02-16 | 简寿慈 | Health-care instant snuff and production method thereof |
CN1105215A (en) * | 1994-01-13 | 1995-07-19 | 孙来顺 | Health-type chewing tobacco |
CN2256216Y (en) * | 1996-09-29 | 1997-06-18 | 赵康修 | Cigarette product |
CN1176075A (en) * | 1997-08-29 | 1998-03-18 | 宋国合 | Combustion-less innoxious cigarette and its preparation |
CN2334193Y (en) * | 1997-05-15 | 1999-08-25 | 李炯 | Ashless cigarette box |
CN1404365A (en) * | 2000-02-16 | 2003-03-19 | 日本烟草产业株式会社 | Method for producing shredded tobacco and production system for use therein |
CN101222861A (en) * | 2005-04-29 | 2008-07-16 | 菲利普莫里斯生产公司 | Tobacco pouch product |
CN101254023A (en) * | 2008-03-13 | 2008-09-03 | 中国烟草总公司郑州烟草研究院 | Nicotine sustained-release type mouth insertion tobacco tablet |
CN103751060A (en) * | 2014-01-21 | 2014-04-30 | 江苏中烟工业有限责任公司 | Nourishing and moisturizing type tobacco gel composition and preparation method thereof |
CN104997929A (en) * | 2015-07-09 | 2015-10-28 | 淮海工学院 | External ointment for smoking cessation |
EP2976951A1 (en) * | 2014-07-21 | 2016-01-27 | JT International S.A. | Method of producing a portioned smokeless tobacco product |
-
2016
- 2016-12-30 CN CN201611257416.7A patent/CN106617263A/en active Pending
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN86106959A (en) * | 1985-09-19 | 1987-05-20 | 贝特莱夫国际公司 | Herbal chewing tobacco and snuff composition |
CN1081908A (en) * | 1993-08-31 | 1994-02-16 | 简寿慈 | Health-care instant snuff and production method thereof |
CN1105215A (en) * | 1994-01-13 | 1995-07-19 | 孙来顺 | Health-type chewing tobacco |
CN2256216Y (en) * | 1996-09-29 | 1997-06-18 | 赵康修 | Cigarette product |
CN2334193Y (en) * | 1997-05-15 | 1999-08-25 | 李炯 | Ashless cigarette box |
CN1176075A (en) * | 1997-08-29 | 1998-03-18 | 宋国合 | Combustion-less innoxious cigarette and its preparation |
CN1404365A (en) * | 2000-02-16 | 2003-03-19 | 日本烟草产业株式会社 | Method for producing shredded tobacco and production system for use therein |
CN101222861A (en) * | 2005-04-29 | 2008-07-16 | 菲利普莫里斯生产公司 | Tobacco pouch product |
CN101254023A (en) * | 2008-03-13 | 2008-09-03 | 中国烟草总公司郑州烟草研究院 | Nicotine sustained-release type mouth insertion tobacco tablet |
CN103751060A (en) * | 2014-01-21 | 2014-04-30 | 江苏中烟工业有限责任公司 | Nourishing and moisturizing type tobacco gel composition and preparation method thereof |
EP2976951A1 (en) * | 2014-07-21 | 2016-01-27 | JT International S.A. | Method of producing a portioned smokeless tobacco product |
CN104997929A (en) * | 2015-07-09 | 2015-10-28 | 淮海工学院 | External ointment for smoking cessation |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108968165A (en) * | 2018-10-10 | 2018-12-11 | 湖北中烟工业有限责任公司 | A method of improving electronic cigarette and aspirates strength |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11129405B2 (en) | Inhibition of sensory irritation during consumption of non-smokeable tobacco products | |
US5845647A (en) | Tobacco and related products | |
US5803081A (en) | Tobacco and related products | |
CN107802032A (en) | A kind of discontinuous temperature causes production method and the application of the fragrant filter stick of phase change gel load | |
WO2020177266A1 (en) | Cigarette core material capable of being lit and capable of being heated at low temperature for suction and preparation method therefor | |
CN104839885A (en) | Improved method for manufacturing electronic cigarette liquid | |
CN110537718A (en) | Method for improving aroma richness and aroma harmony of non-burning heated cigarette | |
CN108926030A (en) | A kind of tobacco style leaf composition for multiple heating mode cigarette, multiple heating mode cigarette and preparation method thereof | |
CN102551193A (en) | Natural Radix Glycyrrhizae extract containing Ama Deli compound and preparation method and application thereof | |
CN104687239B (en) | A kind of tobacco juice for electronic smoke training element rich in ultrafine green tea powder and tea | |
CN106617263A (en) | Ointment-form snuff and preparation method thereof | |
CN110295088B (en) | Cumquat-flavored essence and application thereof | |
CN105029684B (en) | Utilize the method that compounded amino acid fermentation prepares cigar tobacco | |
CN106923373A (en) | A kind of mint aroma smears cigarette and preparation method thereof | |
CN113397204A (en) | Feed liquid formula for traditional cigarette during heating and non-combustion smoking and application | |
CN108185539B (en) | Electronic cigarette with improved sensory quality and manufacturing method thereof | |
CN106723299A (en) | A kind of rose scent smears cigarette and preparation method thereof | |
CN105852192A (en) | Fructus phyllanthi flavored chewing tobacco and preparation method thereof | |
CN106579540A (en) | Ointment type past cigarette and preparation method | |
CN106579541A (en) | Jasmine-flavored smokeless tobacco product and preparation method thereof | |
US5003995A (en) | Compositions and articles for stimulating taste receptors | |
CN106579539A (en) | Fresh-scent type smokeless tobacco product and preparation method thereof | |
CN115216365B (en) | Baking aroma base module, preparation method thereof and application of baking aroma base module in cigarettes | |
CN114587004B (en) | Essence for improving tobacco quality of Indonesia cigar and preparation method thereof | |
CN110801051A (en) | Electronic cigarette oil added with mixed light components of condensed fragrance of cigarettes and preparation method of electronic cigarette oil |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170510 |